Differential fluorescence induction technology was used to identify promoters of Streptococcus pneumoniae genes that are expressed during lung infection of the mouse. Among the promoter clones that were identified multiple times was the psa promoter, which drives expression of the psaBCA operon. These genes have been identified previously and shown to encode a manganese permease system as well as play a role in the virulence of this organism. Mutations in psaB, psaC or psaA result in growth limitation in low manganese. The expression of the psa operon was examined in vivo and the virulence of deletion mutants of psaB, psaC, psaA and psaBCA was assessed in four different animal models of infection. The psa promoter was induced more than ten-fold in vivo using an intraperitoneal chamber implant model. The psaB, psaC and psaA mutants were completely attenuated in systemic, respiratory tract and otitis media infections. In addition, these mutants were unable to grow in an implanted peritoneal chamber, but growth was restored by the addition of manganese to the chambers.
INTRODUCTION
In an attempt to identify novel targets for antimicrobial drug development, we have employed differential fluorescence induction (DFI) technology, which allows the identification of bacterial promoters expressed specifically in a given environment (Valdivia & Falkow, 1996 . This technology relies on the green fluorescent protein (GFP) reporter gene to indicate expression from a given promoter under different experimental conditions. In our application of this technology, random small fragments of chromosomal DNA from Streptococcus pneumoniae were cloned upstream of a promoterless gfp gene on an Escherichia coli-S. pneumoniae Abbreviations : DFI, differential fluorescence induction ; FACS, fluorescence-activated cell sorting ; GFP, green fluorescent protein ; m.c.f., mean channel flourescence ; RTI, respiratory tract infection ; spc, spectinomycin.
shuttle plasmid (Bartilson et al., 2000) . The resulting library was transformed into S. pneumoniae and grown under inducing and non-inducing conditions, and pools of clones grown under the inducing conditions were analysed and sorted by fluorescence-activated cell sorting (FACS). Subsequent rounds of growth followed by sorting resulted in a population enriched for clones containing promoters that are expressed under the inducing conditions. S. pneumoniae is a Gram-positive bacterial pathogen responsible for causing serious community-acquired systemic (bacteraemia, meningitis) as well as more localized (upper respiratory tract, pneumonia, otitis media) infections (Kalin, 1998 ; Paton, 1996 ; Paton et al., 1993 ; Watson et al., 1995) . Such infections are prevalent worldwide, and target especially infant, elderly and immunocompromised patients. One feature of S. pneumoniae pathogenesis that makes its infection so dangerous is its ability to disseminate and cause systemic infection that can progress to meningitis (Reynolds, 1999 ; Watson et al., 1995) . This is in contrast to other causative agents of bacterial pneumonia, and as a result can lead to higher fatality rates for pneumococcal infections.
Several important virulence determinants of this organism have been identified, yet little is known about the expression of these or other virulence factors during infection. In particular, the pneumococcal capsule has been shown to have a profound effect on virulence, with reports of "10'-fold reduction in virulence for capsule mutants (Kalin, 1998 ; Watson et al., 1995) . The role of the capsule in the virulence of S. pneumoniae is not completely understood though it is likely to be important for in vivo survival by preventing phagocytosis of the organism by macrophages. Pneumolysin and autolysin have also been shown to be important for pathogenesis (Canvin et al., 1995 ; Paton, 1996) , likely due to their involvement in cytotoxicity and quorum sensing, respectively. Mutants of S. pneumoniae lacking pneumolysin activity are unable to invade the bloodstream, suggesting that the cytotoxic effect of pneumolysin contributes to the invasive nature of pneumococcal infections (Canvin et al., 1995 ; Mitchell & Andrew, 1997 ; Paton et al., 1997 ; Zysk et al., 2001) . Potential pneumococcal vaccine candidates include PspA and PsaA, two surface proteins that are major immunogens (Brooks-Walter et al., 1999 ; Ogunniyi et al., 2000 ; Srivastava et al., 2000 ; Talkington et al., 1991 Talkington et al., , 1996 .
We have previously used DFI to identify S. pneumoniae promoters induced under certain in vitro laboratory conditions (Bartilson et al., 2000 ; Marra et al., 2002) with the intention of mimicking aspects of the in vivo environment to which a pathogen may respond ; subsequent experiments screened for promoters induced during infection. It was hoped that these identified promoters expressed genes whose functions were necessary for causing infection, and thus interruption of their expression would decrease virulence. The in vivo environment we chose for our screen was the murine lung during a 24 h infection.
Several rounds of infection followed by sorting by flow cytometry yielded a population of S. pneumoniae promoter-probe clones that have been collected on the basis of their high levels of expression during infection (Marra et al., 2002) . Individual clones were isolated and the DNA inserts upstream of gfp were sequenced. In one experiment, a disproportionate number of clones was found to carry the psa promoter indicating that the psaBCA operon is expressed during respiratory tract infection (RTI). The psa genes encode a manganese permease uptake system in S. pneumoniae . psaB, psaC and psaA code for an ATPbinding protein, a transmembrane protein and a lipoprotein, respectively, and their identification has been reported previously Novak et al., 1998 ; Sampson et al., 1994) . PsaA has strong homology to a number of Gram-positive bacterial surface proteins, namely AdcA from S. pneumoniae , FimA from Streptococcus parasanguis (Burnette-Curley et al., 1995) , ScaA from Streptococcus gordonii (Kolenbrander et al., 1998) and SsaB from Streptococcus sanguis (Ganeshkumar et al., 1991) . psa mutants have been shown to require manganese for normal growth and to be attenuated in two murine models of S. pneumoniae infection (Berry & Paton, 1996) . We have extended these virulence studies and report here the analysis of psa expression in vitro and in vivo, and characterization of stable psa replacement mutants in four animal models of S. pneumoniae infection : respiratory tract, systemic, intraperitoneal chamber implant and otitis media.
METHODS
Bacterial strains and growth conditions. All strains used in these studies are derivatives of S. pneumoniae D39, an encapsulated serotype 2 strain (Tiraby et al., 1975) . S. pneumoniae was routinely grown at 37 mC, 7n5% CO # in air either in brain-heart infusion broth (BHIB ; Difco Laboratories) supplemented with 5 % yeast extract or on tryptic-soy agar (TSA) plates containing 5 % defibrinated sheep blood (BBL). Antibiotics were used at the following concentrations : spectinomycin (spc), 500 µg ml − " ; erythromycin, 0n3 µg ml − ". The addition of 2 µM MnSO % was essential for the survival and growth of the psa replacement mutants .
Construction of the S. pneumoniae promoter-probe library and DFI conditions. The S. pneumoniae promoter-trap library in vector pNE1gfp has been described previously (Bartilson et al., 2000) . Briefly, the library consists of 200-500 bp DNase I fragments of S. pneumoniae D39 DNA cloned upstream of the promoterless gfp gene in pNE1gfp. Following ligation, the library was electroporated into E. coli RR1, and plasmid DNA was prepared and used to transform S. pneumoniae D39 as described (Bartilson et al., 2000) . The S. pneumoniae D39 promoter-trap library was used to infect groups of three mice via intranasal instillation ; as a negative control for sorting, D39 carrying the promoterless gfp fusion plasmid pNE1gfp was used to infect another set of mice. In both cases infection was with "10' organisms, which represents full coverage of the library (Bartilson et al., 2000) . Both sets of mice were sacrificed 24 h post-infection and their lungs lavaged with 1 ml sterile PBS. An aliquot of each recovered sample was titred to determine bacterial numbers inside the lungs ; the remainder was pooled and used for sorting by flow cytometry on a FACStar machine (Becton Dickinson) equipped with an argon laser emitting at 488 nm. The sample containing the negative control was also analysed to adjust the gate for background fluorescence. Sorted cells were collected into BHIB containing spc and this suspension was spread onto TSA plates containing 5 % sheep blood and spc. After overnight growth, cells were collected with swabs into PBS and aliquots frozen at k80 mC. After two more rounds of infection and sorting, the resulting population was plated for single colonies, and 96 individual clones were picked for PCR and sequencing of inserts. PCR was performed on an aliquot of exponential-phase cells using the Expand High Fidelity PCR System (Roche Molecular Biochemicals). Insert DNA sequences were compared with the S. pneumoniae genome using the  algorithm at TIGR (http :\\www.tigr.org\) and downstream genes identified using  software (Oxford Molecular). For reasons described below, we focused on one clone that was isolated a disproportionate number of times, which we identified as psa.
Construction of psa null mutants. S. pneumoniae D39 derivatives with replacement mutations in the psa genes were constructed by using plasmid pCZA342 (Hoskins et al., 1999) , which encodes apramycin (for selection in E. coli) and erythromycin (for selection in S. pneumoniae) resistance markers. The strategy for constructing null mutants requires generation of a construct containing a spectinomycinresistance marker (LeBlanc et al., 1991) flanked by PCRgenerated fragments upstream and downstream of the gene to be mutated cloned into pCZA342. Plasmid pCZA342 can replicate in E. coli but not in S. pneumoniae so transformants are screened for an erythromycin-sensitive, spectinomycinresistant phenotype. The primers used for amplification of the cloning fragments were based on the S. pneumoniae unfinished genome sequence at TIGR. For psaA, a 593 bp PstI-XhoI fragment and a 636 bp SacI-BamHI fragment were ligated to the XhoI-SacI spectinomycin-resistance marker and the PstI\ BamHI-digested pCZA342 plasmid. Oligomers used to PCR amplify the cloning fragments flanking the psaA gene were : 5h-ATGCATGCCTGCAGGCTAAAGCCATGGGAATGC-3h ; 5h-ATGCATGCCTCGAGGGTTCGTATTCGTGTGG-3h ; 5h-ATGCATGCGAGCTCCCTATGGTGTCCCAAGTGC3h ; 5h-ATGCATGCGGATCCCGTGTTGTCCAGTCCAG-C-3h.
For psaB, a 467 bp PstI-XhoI fragment and a 442 bp SacI--BamHI fragment were ligated to the XhoI-SacI spectinomycin-resistance marker and the PstI\BamHI-digested pCZA342 plasmid. Oligomers used to PCR amplify the cloning fragments flanking the psaB gene were : 5h-ATGC-ATGCCTGCAGGGGATTTCAGCTGTCTGTTGCC-3h ; 5h-ATGCATGCCTCGAGCCGTTTGGACCAATGATG-C-3h ; 5h-ATGCATGCGAGCTCGGGATTGACTCTGTC-AGTGAGG-3h ; 5h-ATGCATGCGGATCCGGCTCCGATA-AAGAAGTCAAGG-3h.
For psaC, a 594 bp PstI-XhoI fragment and a 593 bp SacI-BamHI fragment were ligated to the XhoI-SacI spectinomycin-resistance marker and the PstI\BamHI-digested pCZA342 plasmid. Oligomers used to PCR amplify the cloning fragments flanking the psaC gene were : 5h-ATGC-ATGCCTGCAGCCTTGAAATCGTCGGCCTAGC-3h ; 5h-ATGCATGCCTCGAGGCAATCCAAAGACAATGG-3h ; 5h-ATGCATGCGAGCTCGCTAAAGCCATGGGAATG-C-3h ; 5h-ATGCATGCGGATCCGGTTCGTATTCGTGT-GG-3h.
For deleting the entire psa operon, a 467 bp PstI-XhoI fragment and a 636 bp SacI-BamHI fragment were ligated to the XhoI-SacI spectinomycin-resistance marker and the PstI\BamHI-digested pCZA342 plasmid. Oligomers used to PCR amplify the cloning fragments flanking the psa operon were : 5h-ATGCATGCCTGCAGGGGATTTCAGCTGTC-TGTTGCC-3h ; 5h-ATGCATGCCTCGAGCCGTTTGGA-CCAATGATGC-3h ; 5h-ATGCATGCGAGCTCCCTATGG-TGTCCCAAGTGC-3h ; 5h-ATGCATGCGGATCCCGTGT-TGTCCAGTCCAGC-3h.
S. pneumoniae D39 cells were transformed with plasmid DNA of the recombinant pCZA342 derivatives that had been purified from E. coli DH12S electrocompetent cells (Gibco-BRL). The transformation of S. pneumoniae required bacterial cells to be in early exponential phase (OD '!! 0n05-0n1) in BHIB containing synthetic competence-stimulating peptide CSP-1 at a final concentration of 0n1 µg ml − ", 10 mM glucose and 10 % horse serum (Sigma). The bacteria were cultured on TSA with 5 % sheep blood and 0n5 g l − " spc (plates prepared by Becton Dickinson) in an atmosphere of 7n5% CO # at 37 mC. Mutants were verified by both Southern blotting and PCR amplifications using primers flanking the cloned regions (not shown). Two independent isolates were characterized for each mutant generated.
In vitro growth of psa mutants in the presence of manganese. Growth curves were produced for all four psa mutants and D39 in BHIB or BHIB supplemented with MnSO % as follows. Strains were inoculated into 1 ml BHIB containing 5 % yeast extract, 500 µg spc ml − " (for psa mutants), 2 µM MnSO % (for psa mutants) and incubated for 6 h at 37 mC, 7n5% CO # . This culture was then used to inoculate 40 ml of the same medium, which was incubated for 16 h at 37 mC, 7n5% CO # . Cultures were centrifuged and the cells washed in PBS, resuspended in BHIB, and the OD '!! measured. Cultures were diluted into 20 ml BHIB containing 2 µM MnSO % , adjusted to OD '!! 0n05 and 1 ml aliquots distributed into 15 ml roundbottom culture tubes. Cultures were incubated at 37 mC, 7n5% CO # and at 1 h intervals, one aliquot from each set of tubes was removed and the OD '!! determined.
Animal infection models
Murine RTI. Bacterial cultures for infection were prepared by inoculating TSA\5 % sheep blood plates containing appropriate antibiotics or manganese with bacteria from frozen stocks. Plates were incubated overnight and growth collected with swabs into PBS. Bacterial suspensions were adjusted so that the OD '!! of a 1 : 10 dilution was approximately 0n3. Female CD-1 mice, aged 6 weeks, were anaesthetized with isoflurane (4 % in O # ) and infected with 50 µl bacterial suspension ("5i10( cells) by intranasal instillation. Five to ten animals were routinely infected per group. Animals were allowed to recover and given food and water ad libitum, and after 48 h were killed by CO # overdose. Blood was collected by cardiac puncture and assayed for viable bacteria by agar plate count ; the lungs were aseptically removed, homogenized in 1 ml PBS in a Stomacher (Labconco), and plated onto agar for viable counts. Each experiment was performed a minimum of two times, and the data shown are composites of all experiments.
Murine systemic infection. Bacterial suspensions were prepared as described above for murine RTI. Suspensions were serially diluted 10-fold in PBS to appropriate concentrations such that mice would receive between 10 and 10' organisms. Female CD-1 mice aged 6 weeks were given 200 µl diluted bacterial suspension by intraperitoneal injection using a 28 gauge tuberculin syringe. Six to ten mice were infected per group ; mice were monitored twice daily and deaths were recorded. LD &! calculations were based on the number of survivors in each group at 22 h post-infection. For each mutant, a second independent isolate was used to infect groups of mice to ensure that the observed results were due to the engineered mutation and not to a second event. The secondary transformants were injected into mice at the D39 LD &! (40-100 cells) and at 1000 times the LD &! ; in all cases the numbers of survivors corroborated the results seen with the primary transformants (data not shown).
Otitis media infections. Bacterial suspensions were prepared as described above and diluted to "10& cells ml − ". Male Mongolian gerbils weighing 25-30 g were anaesthetized with isoflurane (5 % in O # ) and 30 µl bacterial suspension (usually 10$-10% organisms) was injected through the bone of both the right and the left bullae using a 25 g needle attached to a 0n5 ml syringe. Animals were returned to their cages and allowed food and water ad libitum and killed at 96 h post-infection by CO # overdose. Upon killing, the middle ear aspirates were extracted following injection of 100 µl PBS into each middle ear cavity through the tympanic membrane and withdrawal of fluid. Bacteria contained in this aspirate were enumerated following serial dilution and plating for c.f.u. on TSA\5% sheep blood plates containing appropriate antibiotics. In addition, blood was collected by cardiac puncture and numbers of viable bacteria determined by agar plate count.
Murine intraperitoneal chamber implant model. This model requires the construction of diffusion chambers using 1 cm length sections of a 1 ml syringe. Millipore MF 0n22 µm pore size filters were cut to the diameter of the syringe barrels and attached to the ends of the barrels by melting on a hot plate and pressing the molten plastic onto the filter. The entire sealed chamber was then sterilized by autoclaving. Bacteria for inoculating the chambers were prepared by swabbing fresh overnight growth off a TSA\5 % sheep blood plate into PBS and diluting to the desired cell density. Bacteria were injected into the chamber with a needle and the injection site was sealed with a heated glass rod. In some experiments, 20 µM MnSO % was added to the chambers. Mice (female CD-1, age 7-8 weeks) were anaesthetized with 3-4 % isoflurane, and the abdomen shaved and swabbed with betadine. A small longitudinal incision (2-3 cm) was made in the abdomen and one to four chambers placed into the peritoneal cavity. The abdominal wall was then sutured closed using 3\0 gauge silk sutures and the skin stapled closed. Animals were allowed to recover and given food and water ad libitum. At a given time point mice were killed by CO # overdose and chambers were removed aseptically. Bacteria were removed from the chamber using a syringe and viable bacterial counts determined by plating serial dilutions onto TSA plates containing 5 % sheep blood with antibiotic selection, where appropriate. Induction of psa-gfp fusion in vivo. For analysis of psa-gfp fusion expression in vivo, D39 cells carrying the psa-gfp fusion plasmid isolated by multiple rounds of RTI followed by sorting were grown in BHIB containing 5 % yeast extract and spc to exponential phase. Cells were washed in PBS and an aliquot was analysed for fluorescence on a FACS Caliber machine (Becton Dickinson) with an argon laser emitting at 488 nm. The washed cells were also used to load multiple diffusion chambers for peritoneal implant of a mouse. As a negative control, the D39 strain carrying the promoterless gfp fusion plasmid was also loaded into chambers and implanted. After 24 h the chambers were removed and bacteria harvested from the chambers. Recovered bacteria were analysed on the FACS Caliber machine as described above and their fluorescence levels compared to those prior to implant.
RESULTS

Enrichment for promoter clones expressed during infection, and identification of a psaB-gfp fusion clone
The basic approach for DFI technology has been described in detail elsewhere (Bartilson et al., 2000 ; Valdivia & Falkow, 1997) . We have adapted this technology for S. pneumoniae, constructing a random promoter-probe library that relies on GFP expression and FACS following growth of the library under inducing conditions (Bartilson et al., 2000 ; Marra et al., 2002) . Sorting allows for the collection of clones based on their GFP expression, presumably due to a randomly cloned promoter element upstream of the gfp gene that responds to the inducing conditions. Of particular interest to us were genes induced during in vivo infection and we focused our efforts on murine RTI. Following three rounds of RTI and sorting for induced clones, inserts from 100-200 individual randomly picked clones were PCR amplified and sequenced. In several such experiments, the psa-gfp fusion clone was isolated more than once and so we chose it for further study.
Induction of psaB-gfp fusion in vivo
To confirm that the psa operon is induced in vivo, as indicated by DFI, we used D39 carrying the psa-gfp fusion to load diffusion chambers. The inoculum was analysed by flow cytometry (the 'uninduced' condition) and multiple chambers were implanted into the peritoneal cavities of mice. Chambers were recovered at 22 h post-infection and the bacteria harvested from the chambers were again analysed by flow cytometry ('induced' condition). The ratio between induced and uninduced mean channel fluorescence (m.c.f.) values is shown in Table 1 . Two independent experiments indicated that the psa promoter was consistently induced approximately 10-fold in vivo. The negative control, strain D39 carrying the promoterless gfp vector, showed no induction in vivo (not shown).
Characterization of psa null mutants in vitro
We constructed deletion mutants of the individual psa genes and the entire psa operon. To study the trace metal requirements for growth in a psa mutant background, the four psa mutants and the wild-type parent strain were grown in BHIB or BHIB containing manganese, manganese and iron, manganese and zinc, or all three metals at concentrations of 100 µM each. Only manganese stimulated growth of the psa mutants in BHIB (not shown), whereas strain D39 was able to grow to high densities in all five media. Addition of iron or zinc to BHIB did not restore growth to any psa mutants (not shown), and BHIB containing manganese plus the other metals had a similar effect to manganese alone.
We next looked at the growth kinetics of D39 and the four psa mutants in BHIB compared to BHIB supplemented with manganese ( Fig. 1) . D39 was able to grow in unsupplemented BHIB (Fig. 1a) , whereas the four psa mutants showed slight growth between 2 and 4 h but only reached approximately 30 % of the cell density achieved by D39. In contrast, when manganese was added all four psa mutants were capable of growth to approximately 67 % of wild-type levels (Fig. 1b) . Also, the psa mutants have a much shorter lag time than D39 in this medium. Higher concentrations of manganese failed to further increase growth of the mutants.
Characterization of psa mutants in vivo
RTI model. All three psa mutants, as well as the mutant carrying the deletion of the entire psa operon, were used to infect mice by intranasal instillation to establish a RTI. Lung homogenates were titred for bacterial counts 48 h after infection. The results are shown in Fig. 2(a) . The psaA and psaB mutants were unable to colonize the lungs, with homogenates yielding bacterial numbers at or below the limit of detection. In a minority of mice infected with the psaC or the psaBCA mutants, small numbers of bacteria were found in the lungs. In contrast, the mean number of bacteria found in the lungs following infection with the wild-type D39 strain was 10'. Since D39 is known to cause systemic as well as RTI following intranasal inoculation, bacteria in the blood were also enumerated. As expected, the D39 strain was found at very high titres in the blood of intranasally infected mice, often at 10(-10) c.f.u. ml −" . However, none of the psa mutant bacteria were found in the blood after 48 h (Fig. 2b) .
Otitis media infection. In a model of otitis media infection, Mongolian gerbils were infected with one of the four psa mutants or the wild-type strain and middle ear aspirates were collected. As in the RTI model, in this model strain D39 has the ability to disseminate systemically, so blood was also collected from infected animals. Over the 4 days of infection, parental strain D39 can survive and multiply approximately 100 000-fold in the middle ear, and dissemination to the blood is evident, as shown in Fig. 3 . In contrast, no bacteria from any of the psa mutants were recovered from gerbil middle ear cavities (Fig. 3a) . Blood collected from the psa mutant-infected mice 4 days post-infection yielded no detectable bacteria (Fig. 3b) . With the idea of rescuing the psa mutants, in two experiments, a 50-or 500-fold excess of MnSO % was concomitantly injected into the middle ear cavities, yet still no bacteria were recovered (data not shown).
Systemic infection.
To determine the effects of the psa mutations on the ability of this organism to cause systemic infection and death, groups of mice were injected intraperitoneally. with different doses of bacteria and the LD &! for each strain was calculated at 24 h post-infection. Table 2 shows that the LD &! values for the psa mutants are approximately 10 000-fold greater than for the parental strain. In addition, mice infected with any of the psa mutants remained alive for at least 1 week after infection without showing any signs of illness, whereas all mice infected with D39 at any dose died within 3 days. Intraperitoneal chamber implant. To help address the question of whether the decrease in virulence of the psa mutants was due to increased susceptibility to host defences or to a nutritional requirement, we loaded diffusion chambers with either D39 or psa mutants in PBS, implanted them into the peritoneal cavity of mice and measured their ability to multiply over a 24 h period. Strain D39 was able to multiply approximately 1000-fold in this period, reaching levels of 10) c.f.u. ml −" . Mutants psaA, psaB, psaC and the triple mutant all lost viability over 24 h (Fig. 4a) . We wanted to see whether the addition of manganese to the chambers would restore growth to these mutants. As shown in Fig. 4(b) , all four mutant strains grew to wild-type levels when the chambers were supplemented with 20 µM MnSO % . Thus, the attenuated growth phenotype of the psa mutants in the diffusion chambers can be corrected by the addition of excess manganese.
DISCUSSION
The psa genes of S. pneumoniae have been described previously as encoding a manganese uptake system for this organism . Insertion mutations in psaB, psaC or psaA have been demonstrated to have pleiotropic effects, including a growth requirement for added manganese and reduced tranformability , penicillin tolerance, decreased adhesion and attenuation in vivo (Novak et al., 1998) , although several of these findings have been disputed (Claverys et al., 1999) . We have focused on and extended the in vivo studies by constructing more stable replacement mutants and assessing their virulence in different animal models of infection.
We first became interested in the psa locus during a screen for S. pneumoniae promoters induced during infection. Using DFI technology in the murine RTI model, the promoter upstream of psaB was isolated numerous times, indicating that it is strongly induced in vivo. Indeed, subsequent experiments using the murine intraperitoneal chamber implant model have corroborated this observation, showing that the psa promoter is induced approximately ten-fold in vivo.
The effects of these mutations were assessed in four relevant animal infection models, each of which presumably presents a different environment and challenge to the bacteria. In a systemic infection model, the LD &! of all four psa mutants were approximately 10%-fold higher than for D39. Mice infected with even higher numbers of psa mutants survived the study, whereas the D39-infected group had very few survivors at 48 h postinfection, even at the lowest dose. It is worth noting that even when injected with over 10' organisms, mice infected with the psa mutants did not show any signs of illness and did not succumb to infection for at least 7 days. This result is significant in that it demonstrates that the psa system is essential for the survival of this organism in vivo and that the likelihood of a suppressor mutation arising is very low, even under the strong selective pressure that might be expected to be present in vivo.
These mutants are also unable to grow in the relatively protected environment of an intraperitoneally implanted chamber. The wild-type D39 strain can multiply to large numbers, yet very few mutant bacteria were found in the chambers upon harvest. Indeed, it appears that these four mutants die within the chambers, since the numbers of bacteria used to inoculate the chambers were not recovered only 24 h after implant. However, when manganese is added to the chambers prior to implant, the mutants attain wild-type levels. These results together suggest that the mutations in psa are lethal in the absence of accessible manganese, as these mutants seem to lose viability by 24 h even when protected from host cells inside the chambers.
One interesting observation from this experiment is that in the intraperitoneal chambers, D39 was able to grow to high cell densities without lysing, and the psa mutants grown in the presence of manganese showed similar behaviour. This result may indicate that autolysis is more a feature of in vitro growth and does not occur so readily in vivo. Alternatively, autolysin-mediated lysis may be induced in vivo by a host factor that is not accessible to bacteria inside the chambers.
The four psa mutants also had varied effects on virulence in the murine RTI model. psaB and psaA were completely unable to colonize lungs following intranasal inoculation : no bacteria were recovered from any mice infected with these strains. A subset of mice infected with the psaC and the psaBCA mutants, however, showed very low bacterial counts (in the order of 100 c.f.u. per pair of lungs). In both cases the numbers of mice with lung counts at 48 h were approximately 25 % of the total infected. It is not clear whether these counts are due to a low level of bacterial replication or to incomplete clearance by the host ; it is likely to be the latter as these mutants are deletions and therefore cannot revert. The psaBCA result suggests that the deletion of all three genes leads to less severe attenuation than deletion of either gene alone, and that perhaps the absence of one component of the psa system is more deleterious than deletion of the entire system, perhaps by interfering with another uptake pathway(s).
It has been our experience that strain D39 is able to disseminate into the bloodstream following RTI in mice where the lung counts have reached 10%. This bloodstream dissemination following RTI as well as otitis media infection distinguishes S. pneumoniae from other pneumonia-causing organisms and allows this organism to cause more serious, life-threatening infections. The psa mutants do not disseminate into the bloodstream of infected mice, though it is not known whether this is due to their inability to achieve high enough levels in the lungs or whether they are more susceptible to host defences once they do get into the blood. The results of our systemic infections would suggest that both factors are at play. The nutritional defect of the psa mutants may render them less able to overcome host defences.
None of the psa mutants showed any growth in the gerbil otitis media infection, whereas the wild-type parent D39 was able to multiply 10$-10%-fold within 4 days. Not surprisingly, psa mutants do not disseminate into the bloodstream in this model, as does D39. It is interesting to note that it has been reported that alveolar and middle ear macrophages can only weakly phagocytose S. pneumoniae in vitro (Bakaletz et al., 1987 ; Nibbering et al., 1989) , lending support to the idea that these mutants die in the absence of manganese, instead of being more easily phagocytosed.
The importance of trace minerals for bacterial growth in vivo is well known (Jakubovics & Jenkinson, 2001 ), so it is logical that any of the psa mutations would have an adverse effect on virulence, as was predicted by . It is clear that the psa mutants are unable to grow in vitro on even rich medium in the absence of added manganese, therefore these genes are, under most conditions, essential in this organism. In experiments where manganese and other trace metals were added to the medium, the psa mutants could grow but were unable to reach wild-type levels of cell density, even at high manganese concentrations . This result suggests that the psa mutants can take up small amounts of manganese, but for full growth an active uptake system (psa) is necessary.
Previous groups have constructed different psa mutants and studied their virulence. However, these earlier mutants were not complete replacement mutants as we have generated here, but were insertion\duplication mutants. Under selective pressure such mutants are able to revert to wild-type ; indeed it has been demonstrated that there is significant in vivo reversion in a systemic model of infection when large numbers of such mutant bacteria were injected (Berry & Paton, 1996) . Our in vivo analyses of the psa genes clearly demonstrate the importance of this system for the pathogenesis of S. pneumoniae, and indicate that the requirement for manganese is essential for virulence as well as survival. The inability of these mutants to grow in various sites in vivo addresses the issue of nutrient accessibility at these sites.
